Long-term follow-up for kidney transplant patients
Part of Immune system & allergy, Kidney & urinary clinical trials.
This observational study checks kidney transplant outcomes and care over many years by using your existing medical records. It may help researchers understand what happens to transplant patients at 5 and 10 years and improve future follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently enrolled in the OXYOP study.
- You have already completed your OXYOP follow-up visit at 12 months (M12).
- You agree to take part in this additional observational follow-up.
- You are not opposed to researchers using your medical data.
- You are alive, and your transplant (kidney graft) has not been lost before 48 months (M48).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows patients who completed the EVEROLD study to collect long-term health data. It is an observational study that does not test a new treatment.
This is a follow-up study for people who already participated in the STEPS research project about improving fairness in organ transplants. Researchers want to track how participants are doing over time and learn more about transplant outcomes.
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study follows kidney, liver, or heart transplant recipients to better understand how to improve their long-term health and survival. Researchers at several hospitals in France will collect information from participants to learn what helps people stay healthy after a transplant.
This study follows adults who previously received vonsetamig in an earlier study and then got a kidney transplant while enrolled. It mainly looks at what happens after the transplant and helps doctors understand outcomes over time.
Hear when a new Transplant; Complication, Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.